NCT07192419Enrolling by invitation
Promoting Aging and Thriving With HIV
Promoting Aging and Thriving With HIV (PATH)-Implementation of a Tailored Geriatric Assessment and Management Strategy for HIV Care Settings
Source: ClinicalTrials.gov · Last updated 19 Dec 2025
Brief summary (registry, in English)
The pilot is an intervention of a geriatric assessment and management tool (PATH) in outpatient HIV clinics.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 27 Aug 2025
- Start date
- 17 Oct 2025
- Primary completion date
- Sept 2026
- Lead sponsor
- Indiana University
- Diseases
- HIV
- NCT number
- NCT07192419
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 17 Oct 2025 to the primary completion date, Sept 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are receiving geriatric care services, however will liberalize this criteria if difficulty with recruitment
Other
- Patients who are long-term nursing home residents
Who the study is looking for
- Age 50 or older
- Receive HIV care (at least 1 visit at the same site within the past 12 months) from either Eskenazi Health IDC or LifeCare clinics,
- Able to provide informed consent
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IU Health LifeCare Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
| Eskenazi Health Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.